CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 356804-357218 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T55286","span":{"begin":0,"end":152},"obj":"Sentence"},{"id":"T5353","span":{"begin":153,"end":414},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These results identify miRs as MS biomarkers of biological significance and potential clinical value, and reveal new possible therapeutic targets in MS. For children presenting with an initial episode of an acquired demyelinating syndrome (ADS), biomarkers are lacking to predict whose illness will remain monophasic, and who will develop recurrent disease consistent with the diagnosis of multiple sclerosis (MS)."}

{"project":"Epistemic_Statements","denotations":[{"id":"T768","span":{"begin":0,"end":414},"obj":"Epistemic_statement"}],"text":"These results identify miRs as MS biomarkers of biological significance and potential clinical value, and reveal new possible therapeutic targets in MS. For children presenting with an initial episode of an acquired demyelinating syndrome (ADS), biomarkers are lacking to predict whose illness will remain monophasic, and who will develop recurrent disease consistent with the diagnosis of multiple sclerosis (MS)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T62","span":{"begin":0,"end":152},"obj":"Sentence"},{"id":"T63","span":{"begin":153,"end":414},"obj":"Sentence"}],"text":"These results identify miRs as MS biomarkers of biological significance and potential clinical value, and reveal new possible therapeutic targets in MS. For children presenting with an initial episode of an acquired demyelinating syndrome (ADS), biomarkers are lacking to predict whose illness will remain monophasic, and who will develop recurrent disease consistent with the diagnosis of multiple sclerosis (MS)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T799","span":{"begin":216,"end":229},"obj":"Phenotype"}],"attributes":[{"id":"A799","pred":"hp_id","subj":"T799","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"These results identify miRs as MS biomarkers of biological significance and potential clinical value, and reveal new possible therapeutic targets in MS. For children presenting with an initial episode of an acquired demyelinating syndrome (ADS), biomarkers are lacking to predict whose illness will remain monophasic, and who will develop recurrent disease consistent with the diagnosis of multiple sclerosis (MS)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1442","span":{"begin":31,"end":33},"obj":"Body_part"},{"id":"T1443","span":{"begin":149,"end":151},"obj":"Body_part"},{"id":"T1444","span":{"begin":410,"end":412},"obj":"Body_part"}],"attributes":[{"id":"A1442","pred":"uberon_id","subj":"T1442","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A1443","pred":"uberon_id","subj":"T1443","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A1444","pred":"uberon_id","subj":"T1444","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"These results identify miRs as MS biomarkers of biological significance and potential clinical value, and reveal new possible therapeutic targets in MS. For children presenting with an initial episode of an acquired demyelinating syndrome (ADS), biomarkers are lacking to predict whose illness will remain monophasic, and who will develop recurrent disease consistent with the diagnosis of multiple sclerosis (MS)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2317","span":{"begin":31,"end":33},"obj":"Disease"},{"id":"T2318","span":{"begin":149,"end":151},"obj":"Disease"},{"id":"T2319","span":{"begin":390,"end":408},"obj":"Disease"},{"id":"T2320","span":{"begin":410,"end":412},"obj":"Disease"},{"id":"T72100","span":{"begin":31,"end":33},"obj":"Disease"},{"id":"T33326","span":{"begin":149,"end":151},"obj":"Disease"},{"id":"T73521","span":{"begin":390,"end":408},"obj":"Disease"},{"id":"T40392","span":{"begin":410,"end":412},"obj":"Disease"}],"attributes":[{"id":"A2317","pred":"mondo_id","subj":"T2317","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A2318","pred":"mondo_id","subj":"T2318","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A2319","pred":"mondo_id","subj":"T2319","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A2320","pred":"mondo_id","subj":"T2320","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A49762","pred":"mondo_id","subj":"T72100","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A86197","pred":"mondo_id","subj":"T33326","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A27753","pred":"mondo_id","subj":"T73521","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A13572","pred":"mondo_id","subj":"T40392","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"These results identify miRs as MS biomarkers of biological significance and potential clinical value, and reveal new possible therapeutic targets in MS. For children presenting with an initial episode of an acquired demyelinating syndrome (ADS), biomarkers are lacking to predict whose illness will remain monophasic, and who will develop recurrent disease consistent with the diagnosis of multiple sclerosis (MS)."}